Report Update Nov 1, 2024

France - Medicaments Containing Insulin But not Antibiotics - Market Analysis, Forecast, Size, Trends and Insights

Single report

Sent by email within 24h (Mon-Fri)

$599 Basic Edition

$2095 Professional Edition

What's the difference?

Subscription

Online access and download

from $350/month

Get instant access to more than 2 million reports, dashboards, and datasets on the IndexBox Platform.

View Pricing

France: Medicaments Containing Insulin Market 2024

Medicaments Containing Insulin Market Size in France

In 2021, the French medicaments containing insulin market decreased by -28.4% to $X, falling for the second year in a row after two years of growth. Over the period under review, consumption continues to indicate a slight contraction. Medicaments containing insulin consumption peaked at $X in 2019; however, from 2020 to 2021, consumption remained at a lower figure.

Medicaments Containing Insulin Production in France

In value terms, medicaments containing insulin production stood at $X in 2021 estimated in export price. Over the period under review, production saw a relatively flat trend pattern. The pace of growth was the most pronounced in 2016 with an increase of 29% against the previous year. As a result, production attained the peak level of $X. From 2017 to 2021, production growth remained at a somewhat lower figure.

Medicaments Containing Insulin Exports

Exports from France

In 2021, approx. X tons of medicaments containing insulin but not antibiotics were exported from France; reducing by -81.2% compared with the year before. In general, exports, however, enjoyed a strong increase. The growth pace was the most rapid in 2020 when exports increased by 477%. As a result, the exports reached the peak of X tons, and then shrank sharply in the following year.

In value terms, medicaments containing insulin exports contracted markedly to $X in 2021. Overall, exports, however, saw resilient growth. The most prominent rate of growth was recorded in 2020 when exports increased by 351% against the previous year. As a result, the exports attained the peak of $X, and then dropped significantly in the following year.

Exports by Country

New Caledonia (X kg), French Polynesia (X kg) and the UK (X kg) were the main destinations of medicaments containing insulin exports from France, with a combined 100% share of total exports.

From 2012 to 2021, the most notable rate of growth in terms of shipments, amongst the main countries of destination, was attained by New Caledonia (with a CAGR of +23.0%), while the other leaders experienced more modest paces of growth.

In value terms, New Caledonia ($X) emerged as the key foreign market for medicaments containing insulin but not antibiotics exports from France, comprising 59% of total exports. The second position in the ranking was held by French Polynesia ($X), with a 27% share of total exports.

From 2012 to 2021, the average annual rate of growth in terms of value to New Caledonia amounted to +21.5%. Exports to the other major destinations recorded the following average annual rates of exports growth: French Polynesia (+6.3% per year) and the UK (0.0% per year).

Export Prices by Country

The average medicaments containing insulin export price stood at $X per ton in 2021, with an increase of 28% against the previous year. Overall, the export price, however, continues to indicate a slight curtailment. The growth pace was the most rapid in 2016 an increase of 48% against the previous year. Over the period under review, the average export prices reached the peak figure at $X per ton in 2012; however, from 2013 to 2021, the export prices remained at a lower figure.

There were significant differences in the average prices for the major export markets. In 2021, amid the top suppliers, the country with the highest price was New Caledonia ($X per ton), while the average price for exports to the UK ($X per ton) was amongst the lowest.

From 2012 to 2021, the most notable rate of growth in terms of prices was recorded for supplies to the United Arab Emirates (+15.5%), while the prices for the other major destinations experienced a decline.

Medicaments Containing Insulin Imports

Imports into France

In 2021, supplies from abroad of medicaments containing insulin but not antibiotics decreased by -98.1% to X kg for the first time since 2011, thus ending a nine-year rising trend. Over the period under review, imports saw a drastic downturn. The pace of growth appeared the most rapid in 2020 when imports increased by 73% against the previous year. As a result, imports attained the peak of X tons, and then dropped significantly in the following year.

In value terms, medicaments containing insulin imports fell markedly to $X in 2021. In general, imports saw a deep contraction. The most prominent rate of growth was recorded in 2020 with an increase of 83%. As a result, imports attained the peak of $X, and then dropped rapidly in the following year.

Imports by Country

In 2021, Denmark (X kg) was the main supplier of medicaments containing insulin to France, accounting for a approx. 98% share of total imports.

From 2012 to 2021, the average annual rate of growth in terms of volume from Denmark stood at -25.6%.

In value terms, Denmark ($X) constituted the largest supplier of medicaments containing insulin but not antibiotics to France.

From 2012 to 2021, the average annual growth rate of value from Denmark amounted to -24.0%.

Import Prices by Country

The average medicaments containing insulin import price stood at $X per ton in 2021, dropping by -1.8% against the previous year. Over the last nine years, it increased at an average annual rate of +1.4%. The pace of growth appeared the most rapid in 2020 an increase of 5.6% against the previous year. As a result, import price attained the peak level of $X per ton, and then fell slightly in the following year.

As there is only one major supplying country, the average price level is determined by prices for Denmark.

From 2012 to 2021, the rate of growth in terms of prices for Denmark amounted to +2.2% per year.

Source: IndexBox Platform

Frequently Asked Questions (FAQ) :

What are the largest markets for medicaments containing insulin but not antibiotics in the world?

The country with the largest volume of medicaments containing insulin consumption was Denmark, accounting for 58% of total volume. Moreover, medicaments containing insulin consumption in Denmark exceeded the figures recorded by the second-largest consumer, the U.S., sevenfold. The third position in this ranking was occupied by Pakistan, with a 3.6% share.

What are the largest producers of medicaments containing insulin but not antibiotics in the world?

The country with the largest volume of medicaments containing insulin production was the U.S., comprising approx. 80% of total volume. Moreover, medicaments containing insulin production in the U.S. exceeded the figures recorded by the second-largest producer, Denmark, more than tenfold. Pakistan ranked third in terms of total production with a 2.5% share.

What are the leading suppliers of medicaments containing insulin but not antibiotics to France?

In value terms, Denmark constituted the largest supplier of medicaments containing insulin to France.

What are the leading importers of medicaments containing insulin but not antibiotics from France?

In value terms, India emerged as the key foreign market for medicaments containing insulin exports from France, comprising 79% of total exports. The second position in the ranking was occupied by New Caledonia, with a 15% share of total exports.

What is the average export price for medicaments containing insulin but not antibiotics in France?

In 2020, the average medicaments containing insulin export price amounted to $333 per kg, jumping by 65% against the previous year.

What is the average import price for medicaments containing insulin but not antibiotics in France?

The average medicaments containing insulin import price stood at $56,487 per ton in 2020, falling by -29% against the previous year.

This report provides an in-depth analysis of the medicaments containing insulin market in France. Within it, you will discover the latest data on market trends and opportunities by country, consumption, production and price developments, as well as the global trade (imports and exports). The forecast exhibits the market prospects through 2030.

Product coverage:

Prodcom 21201230 - Medicaments containing insulin but not antibiotics, for therapeutic or prophylactic uses, not put up in measured doses or for retail sale

Country coverage:

France

Data coverage:

Market volume and value
Per Capita consumption
Forecast of the market dynamics in the medium term
Trade (exports and imports) in France
Export and import prices
Market trends, drivers and restraints
Key market players and their profiles

Reasons to buy this report:

Take advantage of the latest data
Find deeper insights into current market developments
Discover vital success factors affecting the market

This report is designed for manufacturers, distributors, importers, and wholesalers, as well as for investors, consultants and advisors.

In this report, you can find information that helps you to make informed decisions on the following issues:

How to diversify your business and benefit from new market opportunities
How to load your idle production capacity
How to boost your sales on overseas markets
How to increase your profit margins
How to make your supply chain more sustainable
How to reduce your production and supply chain costs
How to outsource production to other countries
How to prepare your business for global expansion

While doing this research, we combine the accumulated expertise of our analysts and the capabilities of artificial intelligence. The AI-based platform, developed by our data scientists, constitutes the key working tool for business analysts, empowering them to discover deep insights and ideas from the marketing data.

1. INTRODUCTION

Making Data-Driven Decisions to Grow Your Business
1. REPORT DESCRIPTION
2. RESEARCH METHODOLOGY AND AI PLATFORM
3. DATA-DRIVEN DECISIONS FOR YOUR BUSINESS
4. GLOSSARY AND SPECIFIC TERMS
2. EXECUTIVE SUMMARY

A Quick Overview of Market Performance
1. KEY FINDINGS
2. MARKET TRENDS This Chapter is Available Only for the Professional Edition PRO
3. MARKET OVERVIEW

Understanding the Current State of The Market and Its Prospects
1. MARKET SIZE
2. MARKET STRUCTURE
3. TRADE BALANCE
4. PER CAPITA CONSUMPTION
5. MARKET FORECAST TO 2030
4. MOST PROMISING PRODUCT

Finding New Products to Diversify Your Business
This Chapter is Available Only for the Professional Edition PRO
1. TOP PRODUCTS TO DIVERSIFY YOUR BUSINESS
2. BEST-SELLING PRODUCTS
3. MOST CONSUMED PRODUCT
4. MOST TRADED PRODUCT
5. MOST PROFITABLE PRODUCT FOR EXPORT
5. MOST PROMISING SUPPLYING COUNTRIES

Choosing the Best Countries to Establish Your Sustainable Supply Chain
This Chapter is Available Only for the Professional Edition PRO
1. TOP COUNTRIES TO SOURCE YOUR PRODUCT
2. TOP PRODUCING COUNTRIES
3. TOP EXPORTING COUNTRIES
4. LOW-COST EXPORTING COUNTRIES
6. MOST PROMISING OVERSEAS MARKETS

Choosing the Best Countries to Boost Your Exports
This Chapter is Available Only for the Professional Edition PRO
1. TOP OVERSEAS MARKETS FOR EXPORTING YOUR PRODUCT
2. TOP CONSUMING MARKETS
3. UNSATURATED MARKETS
4. TOP IMPORTING MARKETS
5. MOST PROFITABLE MARKETS
7. PRODUCTION

The Latest Trends and Insights into The Industry
1. PRODUCTION VOLUME AND VALUE
8. IMPORTS
The Largest Import Supplying Countries
1. IMPORTS FROM 2012–2023
2. IMPORTS BY COUNTRY
3. IMPORT PRICES BY COUNTRY
9. EXPORTS
The Largest Destinations for Exports
1. EXPORTS FROM 2012–2023
2. EXPORTS BY COUNTRY
3. EXPORT PRICES BY COUNTRY
10. PROFILES OF MAJOR PRODUCERS

The Largest Producers on The Market and Their Profiles
This Chapter is Available Only for the Professional Edition PRO
LIST OF TABLES
1. Key Findings In 2023
2. Market Volume, In Physical Terms, 2012–2023
3. Market Value, 2012–2023
4. Per Capita Consumption In 2012-2023
5. Imports, In Physical Terms, By Country, 2012–2023
6. Imports, In Value Terms, By Country, 2012–2023
7. Import Prices, By Country Of Origin, 2012–2023
8. Exports, In Physical Terms, By Country, 2012–2023
9. Exports, In Value Terms, By Country, 2012–2023
10. Export Prices, By Country Of Destination, 2012–2023
LIST OF FIGURES
1. Market Volume, In Physical Terms, 2012–2023
2. Market Value, 2012–2023
3. Market Structure – Domestic Supply vs. Imports, In Physical Terms, 2012-2023
4. Market Structure – Domestic Supply vs. Imports, In Value Terms, 2012-2023
5. Trade Balance, In Physical Terms, 2012-2023
6. Trade Balance, In Value Terms, 2012-2023
7. Per Capita Consumption, 2012-2023
8. Market Volume Forecast to 2030
9. Market Value Forecast to 2030
10. Products: Market Size And Growth, By Type
11. Products: Average Per Capita Consumption, By Type
12. Products: Exports And Growth, By Type
13. Products: Export Prices And Growth, By Type
14. Production Volume And Growth
15. Exports And Growth
16. Export Prices And Growth
17. Market Size And Growth
18. Per Capita Consumption
19. Imports And Growth
20. Import Prices
21. Production, In Physical Terms, 2012–2023
22. Production, In Value Terms, 2012–2023
23. Imports, In Physical Terms, 2012–2023
24. Imports, In Value Terms, 2012–2023
25. Imports, In Physical Terms, By Country, 2023
26. Imports, In Physical Terms, By Country, 2012–2023
27. Imports, In Value Terms, By Country, 2012–2023
28. Import Prices, By Country Of Origin, 2012–2023
29. Exports, In Physical Terms, 2012–2023
30. Exports, In Value Terms, 2012–2023
31. Exports, In Physical Terms, By Country, 2023
32. Exports, In Physical Terms, By Country, 2012–2023
33. Exports, In Value Terms, By Country, 2012–2023
34. Export Prices, By Country Of Destination, 2012–2023